跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 62 条关于
“LGMD2i/R9”
全部
62
临床试验
32
药物
8
机构
0
资讯
22
9个月前
Cure Rare Disease Secures $7.4 Million CIRM Grant for Novel Gene Therapy Targeting LGMD2i/R9
去年
BridgeBio's BBP-418 Completes Enrollment in Phase 3 Trial for LGMD2I/R9
去年
AskBio's AB-1003 Receives FDA Designations for LGMD2I/R9 Treatment
去年
AskBio's AB-1003 Receives FDA Rare Pediatric Disease and Orphan Drug Designations for LGMD2I/R9
去年
AskBio Advances Phase 1/2 Gene Therapy Trial for Rare Muscular Dystrophy with Second Cohort Dosing
10个月前
BridgeBio Reports Positive Phase 3 Results for BBP-418 in Rare Muscular Dystrophy
11个月前
AskBio Reports Positive Interim Safety Data for AB-1003 Gene Therapy in Rare Muscular Dystrophy Trial
去年
BridgeBio's Attruby Sees Strong Early Demand; Phase 3 Trials Fully Enrolled
2年前
Atamyo Therapeutics Advances Gene Therapy Programs for Limb-Girdle Muscular Dystrophy
去年
BridgeBio Reports Positive Pipeline Progress and Q3 2024 Financial Results
第 1 页,共 3 页
上一页
下一页